Oral Anticoagulants, Proton Pump Inhibitors, and Fracture-Reference-Cited by-同舟云学术

Oral Anticoagulants, Proton Pump Inhibitors, and Fracture

Published:2020-04-01 Issue:4 Volume:180 Page:617
ISSN:2168-6106
Container-title:JAMA Internal Medicine
language:en
Short-container-title:JAMA Intern Med

Author:

Uzoigwe Chika Edward¹,Sanchez Franco Luis Carlos²,Gascon Conde Ignacio³

Affiliation:

1. Department of Medicine, Harcourt House, Sheffield, United Kingdom

2. Department of Gastroenterology, Stepping Hill Hospital, Stockport, United Kingdom

3. Department of Medicine and Nursing, University of Cordoba, Cordoba, Spain

Publisher

American Medical Association (AMA)

Subject

Internal Medicine

Link

https://jamanetwork.com/journals/jamainternalmedicine/articlepdf/2763749/jamainternal_uzoigwe_2020_le_200005.pdf

Reference5 articles.

1. Association of anticoagulant therapy with risk of fracture among patients with atrial fibrillation.;Lutsey;JAMA Intern Med

2. Direct oral anticoagulant use and subsequent start of proton pump inhibitors as proxy for gastric complaints.;Zielinski;Pharmacoepidemiol Drug Saf,2018

3. Proton pump inhibitors and fracture: do they do what it says on the tin?;Uzoigwe;Osteoporos Int,2016

4. Association of oral anticoagulants and proton pump inhibitor cotherapy with hospitalization for upper gastrointestinal tract bleeding.;Ray;JAMA,2018

5. US Food and Drug Administration. FDA drug safety communication: possible increased risk of fractures of the hip, wrist, and spine with the use of proton pump inhibitors. Updated March 23, 2011. Accessed February 12, 2020. https://www.fda.gov/drugs/postmarket-drug-safety-information-patients-and-providers/fda-drug-safety-communication-possible-increased-risk-fractures-hip-wrist-and-spine-use-proton-pump